News

Endocrinology Advisor2d
Oral Semaglutide 25mg Under Review for Chronic Weight Management
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Applied Clinical Trials Online6d
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...